The moderate AUC of the TIM-3 gene expression of 0.706 suggests that probably it could be a relatively efficient negative biomarker that could distinguish patients with B-ALL from healthy individuals. Here, HAVCR2 is linked to precursor B-cell acute lymphoblastic leukemia.